The agreement will enable Fuse Medical to create new cervical and lumbar spinal interbodies, soft tissue fixation devices and other orthopedic implants with OPM’s proprietary 3D printing, according to a July 5 news release. OPM’s OsteoFab technology features bonelike mechanics, bone ongrowth, radiolucency and antibacterial/antiviral properties.
“As OPM focuses on providing advanced implantable polymers and contract manufacturing services, we look to work with industry leaders that are dedicated to innovative solutions that drive medical device technology forward in ways that reduce system costs and improve patient outcomes,” OPM founder and CEO Scott DeFelice said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.